Targeting of the transcription factor Max during apoptosis:: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1

被引:102
作者
Krippner-Heidenreich, A
Talanian, RV
Sekul, R
Kraft, R
Thole, H
Ottleben, H
Lüscher, B
机构
[1] Klinikum RWTH, Inst Biochem, Abt Biochem & Mol Biol, D-52057 Aachen, Germany
[2] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany
[3] Abbott Biores Ctr, Worcester, MA 01605 USA
[4] Graffin GmbH, D-61920 Heidelberg, Germany
[5] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
[6] Hannover Med Sch, Kinderklin, D-30623 Hannover, Germany
关键词
caspase-7; c-Myc; DNA binding; IC50; protein kinase CK2;
D O I
10.1042/0264-6021:3580705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Max is the central component of the Myc/Max/Mad network of transcription factors that regulate growth, differentiation and apoptosis. Whereas the Myc and Mad genes and proteins are highly regulated, Max expression is constitutive and no posttranslational regulation is known. We have found that Max is targeted during Fas-induced apoptosis. Max is first dephosphorylated and subsequently cleaved by caspases. Two specific cleavage sites for caspases in Max were identified, one at IEVE(10)down arrowS and one at SAFD(135)down arrowG near the C-terminus, which are cleaved in vitro by caspase-5 and caspase-7 respectively. Mutational analysis indicates that both sites are also used in vivo. Thus Max represents the first caspase-5 substrate. The unusual cleavage after a glutamic acid residue is observed only with full-length, DNA-binding competent Max protein but not with corresponding peptides, suggesting that structural determinants might be important for this activity. Furthermore, cleavage by caspase-5 is inhibited by the protein kinase CK2-mediated phosphorylation of Max at Ser-11, a previously mapped phosphorylation site in vivo. These findings suggest that Fas-mediated dephosphorylation of Max is required for cleavage by caspase-5. The modifications that occur on Max in response to Fas signalling affect the DNA-binding activity of Max/Max homodimers. Taken together, our findings uncover three distinct processes, namely dephosphorylation and cleavage by caspase-5 and caspase-7, that target Max during Fas-mediated apoptosis, suggesting the regulation of the Myc/Max/Mad network through its central component.
引用
收藏
页码:705 / 715
页数:11
相关论文
共 60 条
[1]   Function of the c-Myc oncoprotein in chromatin remodeling and transcription [J].
Amati, B ;
Frank, SR ;
Donjerkovic, D ;
Taubert, S .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (03) :M135-M145
[2]  
An B, 1996, CANCER RES, V56, P438
[3]   Transcription abnormalities potentiate apoptosis of normal human fibroblasts [J].
Andera, L ;
Wasylyk, B .
MOLECULAR MEDICINE, 1997, 3 (12) :852-863
[4]   High level calcineurin activity predisposes neuronal cells to apoptosis [J].
Asai, A ;
Qiu, JH ;
Narita, Y ;
Chi, S ;
Saito, N ;
Shinoura, N ;
Hamada, H ;
Kuchino, Y ;
Kirino, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :34450-34458
[5]   Characterization of the transcriptional regulator YY1 - The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAF(II)55, or cAMP-responsive element-binding protein (CBP)-binding protein [J].
Austen, M ;
Luscher, B ;
LuscherFirzlaff, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1709-1717
[6]   Phosphorylation of I kappa B-alpha inhibits its cleavage by caspase CPP32 in vitro [J].
Barkett, M ;
Xue, D ;
Horvitz, HR ;
Gilmore, TD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) :29419-29422
[7]   CASEIN KINASE-II INHIBITS THE DNA-BINDING ACTIVITY OF MAX HOMODIMERS BUT NOT MYC MAX HETERODIMERS [J].
BERBERICH, SJ ;
COLE, MD .
GENES & DEVELOPMENT, 1992, 6 (02) :166-176
[8]   Cleavage of the serum response factor during death receptor-induced apoptosis results in an inhibition of the c-FOS promoter transcriptional activity [J].
Bertolotto, C ;
Ricci, JE ;
Luciano, F ;
Mari, B ;
Chambard, JC ;
Auberger, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) :12941-12947
[9]  
BOUSSET K, 1993, ONCOGENE, V8, P3211
[10]  
CERNI C, 1995, ONCOGENE, V11, P587